.svg){kind=small}
Our Services
MHRA Clinical Trial Application Derisking
Strategic review of documents (e.g. IBs, CSPs, GNAs), REC preparation, and global alignment
Scientific Advice Support
End-to-end support for MHRA interactions—briefing book writing, question development, and mock meetings
Accelerated Pathways (e.g., ILAP)
Strategy development, workshop delivery, document authoring, and submission
Paediatric Investigation Plans (PIPs)
Regulatory intelligence, strategy, and submission (incl. waivers, deferrals, and PDCO responses)
Regulatory Roadmaps
Tailored plans from discovery through post-marketing, aligned with your product type, timeline, and markets
Cross-Functional Integration
Support that bridges clinical, regulatory, CMC, and commercial teams
Meet Lisa Campbell
Lisa Campbell leads Richmond Pharmacology’s Regulatory Strategy and Medical Writing teams. With over 20 years of experience spanning regulatory science, clinical medicine, and drug development, Lisa offers unique insight and practical strategy.
Previously a Senior Medical Assessor at the MHRA, Lisa contributed to the development of the Innovative Licensing and Access Pathway (ILAP) and assessed complex trial designs including adaptive and first-in-human studies. She has advised on global clinical programmes for gene therapies, rare diseases, and emerging technologies.
Lisa is an expert in regulatory compliance, trial design, and public policy. She is published in Nature Medicine, BMJ Open, and JAMA. Her areas of interest include Patient-Focused Drug Development and the integration of patient perspectives into clinical research and regulatory strategy.
At Richmond, Lisa ensures that clients receive intelligent, compliant, and patient-centred regulatory guidance, accelerating access to innovative therapies.
Contact us today to discuss how we can support your clinical development with expert, compliant, and forward-thinking regulatory solutions.
.avif)
Latest news
Richmond Pharmacology Appoints Patrick Ramiah as Director of Clinical Project Delivery & Operational Excellence
Events
JSCPT 2025
